By Nigam Arora & Dr. Natasha Arora
One Of The Best Opportunities
India remains one of the best opportunities for very long term investors due to its young demographics and rapidly developing economy. India can sustain a very high growth rate for a very long time.
Outperformance
Please click here for a chart comparing India ETF EPI to emerging markets ETF EEM.
EEM represents the benchmark for emerging markets just like S&P 500 ETF SPY represents the benchmark for the U. S. stock market.
The chart shows that since the beginning of 2021, EPI has outperformed EEM by 33.48%.
Budget
The central government budget represents a major event for the Indian economy. The latest budget was just released. Here are the key points:
- The budget contains a massive spending plan to boost the Indian economy.
- While spending, the budget marginally trims the fiscal deficit.
- The budget contains a master plan for new highways and cargo terminals.
- The budget rose above the politics to spur growth.
- The budget indicates that India will introduce an official cryptocurrency.
All in all, the budget is positive for the Indian economy.
Valuation
From a valuation perspective, the Indian market is very expensive. One reason the market is expensive is that many foreign investors recognize the growth potential and are putting a lot of money to work in India.
It is important to buy on a pull-back and not right here.
Buy Zone
For those following the Best Way, the buy zone to start a scale in is 🔒 (To see the locked content, please take a 30 day free trial) . EPI closed at $37.20.
Ratings
The short-term rating is 🔒 but will likely become a buy if EPI dips into the buy zone. The medium-term rating is 🔒. the long-term rating is 🔒.
This post was just published on ZYX Emerging Markets ETF Alerts.
You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
